Klichinsky Michael (CIK 1967221) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-08). Recent activity: Sell CARM (56,982 shares), Buy CARM (56,982 shares), Sell CARM (165,000 shares), Sell CARM (200,000 shares), Sell CARM (119,347 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-08 | Carisma Therapeutics Inc. (CARM) | Chief Scientific Officer | Sell | 56,982 | $14,246 |
| 2025-10-08 | Carisma Therapeutics Inc. (CARM) | Chief Scientific Officer | Buy | 56,982 | $6,268 |
| 2025-10-03 | Carisma Therapeutics Inc. (CARM) | Chief Scientific Officer | Sell | 165,000 | $42,900 |
| 2025-10-03 | Carisma Therapeutics Inc. (CARM) | Chief Scientific Officer | Sell | 200,000 | $50,000 |
| 2025-10-03 | Carisma Therapeutics Inc. (CARM) | Chief Scientific Officer | Sell | 119,347 | $31,030 |
Source: SEC Form 4 filings · as of 2025-10-08